Voya Financial, Inc. current report, 01 November 2022

Voya Financial, Inc. 8-K Filing Summary

Business Context and Reporting Period

This Form 8-K, dated November 1, 2022, reports that Voya Financial, Inc. ("Voya") entered into a definitive Agreement and Plan of Merger to acquire Benefitfocus, Inc. ("Benefitfocus"). The transaction involves a merger with a wholly-owned subsidiary of Voya, with Benefitfocus surviving as the entity.

Key Financial Metrics and Transaction Terms

  • Merger Consideration: $10.50 per share in cash for each outstanding share of Benefitfocus Common Stock.
  • Preferred Stock: Series A Convertible Preferred Stock will be converted into cash equal to the Convertible Preferred Liquidation Amount.
  • Termination Fee: Benefitfocus is required to pay Voya a termination fee of $14,000,000 under specific circumstances, such as accepting a superior proposal or a change in recommendation by the Benefitfocus Board.
  • Equity Support: Support agreements were executed with BuildGroup Management, LLC and Indaba Capital Management, L.P., representing approximately 24% of Benefitfocus's outstanding voting power, to vote in favor of the merger.
  • Financial Performance: The filing text does not provide specific revenue, profit, cash flow, margin, debt, or liquidity metrics for Voya or Benefitfocus.

Material Changes and Conditions

The consummation of the merger is subject to several material conditions, including:

  • Approval by holders of a majority of Benefitfocus's outstanding shares (Common and Preferred voting as a single class).
  • Expiration of the statutory waiting period under the Hart-Scott-Rodino Antitrust Improvements Act (HSR Approval).
  • Absence of any law or order preventing the transaction.
  • Absence of a Material Adverse Effect as defined in the agreement.
  • Accuracy of representations and warranties and compliance with covenants.

The agreement includes a "no-shop" provision, though Benefitfocus retains a fiduciary out to consider superior proposals under specific conditions prior to stockholder approval.

Guidance, Outlook, and Risks

Timeline: The transaction must be consummated by April 30, 2023 (the "Outside Date"), which may be extended to June 30, 2023 if all conditions are satisfied except for HSR approval.

Risks and Contingencies: The filing highlights significant risks, including the failure to obtain regulatory or stockholder approval, disruption of Benefitfocus operations, employee retention issues, and the diversion of management attention. The transaction is not subject to a financing condition.

Equity Award Treatment: Vested options and certain specified awards will be cashed out. Other RSUs and PSUs will generally be assumed by Voya and converted into Voya RSUs based on an exchange ratio, while awards held by non-continuing employees or directors will be cashed out.

Investor Verification Checklist

  • Verify the final approval status of the merger by Benefitfocus stockholders.
  • Monitor the status of HSR antitrust clearance and any other required regulatory approvals.
  • Review the full text of the Merger Agreement (Exhibit 2.1) for detailed definitions of "Material Adverse Effect" and "Superior Proposal."
  • Assess the potential impact of the $14 million termination fee on the transaction's economics if the deal fails.
  • Confirm the treatment of specific employee equity awards if the transaction closes.